NCT02181465View on ClinicalTrials.gov

Study to Assess Safety and Tolerability of G17DT in Patients With Colorectal Adenocarcinoma.

PHASE2CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

October 31, 1993

Primary Completion Date

May 31, 1994

Study Completion Date

May 31, 1994

Conditions
Colorectal Cancer
Interventions
BIOLOGICAL

G17DT

Trial Locations (1)

Unknown

University Hospital, Queen's Medical Centre, Nottingham

Sponsors
All Listed Sponsors
lead

Cancer Advances Inc.

INDUSTRY

NCT02181465 - Study to Assess Safety and Tolerability of G17DT in Patients With Colorectal Adenocarcinoma. | Biotech Hunter | Biotech Hunter